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Much of the controversy in relation to the relative value of psychodynamic psychotherapy is 
fought in relation to short term psychodynamic psychotherapy, prototypically in the treatment of  
depression (P. Fonagy, 2015; Leichsenring et al., 2015). A recent review by Cuijpers and 
colleagues suggested that Hans Eysenck was correct in his evaluation of psychotherapy; when 
adjusted for several sources of bias, psychotherapy for depression had at best small effects on 
the outcome in terms of symptomatic benefit (Cuijpers, Karyotaki, Reijnders, & Ebert, 2018). But 
nothing is straight forward in this field. When four key methodological parameters were 
controlled for (adequate generation of allocation sequence, the concealment of allocation to 
conditions, the prevention of knowledge of the allocated intervention - masking of assessors - 
and dealing with incomplete outcome data - whether or not intention-to-treat analyses were 
conducted) and waiting list control studies were excluded psychodynamic psychotherapy based 
on five studies had moderate effect size (g=.43, 95% CI .10-.77) compared to CBT (g=.36, 95% 
CI .27-.45). Importantly, despite rumours to the contrary, in weeding out high risk of bias 
studies, the cull had least impact on the psychodynamic modality, leaving 50% of the original 
sample designated as ‘low risk of bias’.  
 
There is little point entering the methodological horse race debate.  Real life, ‘outcome based 
evidence’ observational studies rarely yield meaningful differences between therapeutic 
modalities (Pybis, Saxon, Hill, & Barkham, 2017).  In any case, the conceptual frame of 
reference for psychodynamic psychotherapy is not in a 10-15 session implementation, but in 
observations associated with specific benefit of long term interventions relative to short term 
less intensive psychotherapies.  In this domain, the most recent meta-analysis has provided 
relatively encouraging findings (Woll & Schönbrodt, 2018, August 18). The meta-analysis 
reports 14 studies and an effect size of .24 on psychiatric symptoms (95% CI .06-.42) and a 
larger effect of .35 on social functioning (95% CI .11-.59). So there is evidence for long term 
psychoanalytic psychotherapy, but is it good enough? 
 
The work of Professor Leuzinger-Bohleber at the Sigmund Freud Institute and Professor Martin 
Hautzinger from the University of Tubingen falls into the category of carefully conducted studies 
with minimal risk of bias yielding important results for clinical practice but without dramatically 
modifying our understanding of either the nature of depression or its effective treatment by two 
of the most commonly used therapeutic approaches. The study is unique in comparing long 
term psychoanalytic psychotherapy with cognitive behaviour approach offered for an effectively 
unlimited duration.  I know of no other study where this comparison has even been attempted let 
alone delivered with magnificent clarity and rigor. The companion papers send a number of 
clear explicit and implicit messages to clinicians embattled with cases which present as severe 
or very severe on the depression spectrum.  It is explicit that an approach which shows its 
commitment to the client by offering relatively long term therapy is worthwhile. To be able to 
confidently state to patients that in almost two thirds of cases (61%) persistence will yield 
remission is a highly significant contribution. It is implicit that psychoanalytic therapy is not the 
only approach that will achieve long term benefit.  Psychoanalysts have to give up their claim to 
be unique in providing a therapy with lasting benefit and have to be modest in terms of the 
length of time they to achieve benefit relative to other orientations. Nevertheless, they do as well 
as CBT therapists and there is no evidence of superiority associated with CBT even if the 
primary measure of outcome is likely to be slightly reactive (the BDI measure slightly favours the 
CBT approach because it focuses on cognitions as primary indicators of depression).   
 
It is also important that in a complex design which intended to adopt a naturalistic stance of 
allowing a proportion of the patients to choose their preferred mode of treatment, being given 
treatment choice appeared to have little influence on therapeutic outcome. Randomisation 
certainly did not interfere with outcomes, so the study may be a poster child for showing no 
negative impact accompanies participation in a clinical trial.  The findings also help overturn a 
prior unrepresentative result which suggested that psychodynamic psychotherapy, but not 
cognitive behaviour therapy, was restricted in its effectiveness to client groups which declared a 
preference for this mode of therapy (P. Fonagy, 2010; Watzke et al., 2010).  It is interesting to 
note that many patients recruited for this study had a treatment preference. It is also interesting 
that notwithstanding the incessant drumbeat for CBT as the treatment of choice, many 
expressed preference for the psychodynamic approach when this was clearly described to 
them.  However, the large number that had a preference in combination with the naturalistic 
design which allowed assignment by preference, had the unfortunate consequence of 
preventing the trialists from formally evaluating an equivalence effect in relation to those whio 
were successfully randomised to CBT or psychoanalytic psychotherapy.  A limitation in one 
way, but it also made the study findings more generalisable to a real world setting where real 
patients with real depression have real preferences.  The generalisability of randomised 
controlled trial methodology, when administered in its purest form, is undoubtedly exaggerated 
and the design is overvalued (P Fonagy et al., 2014).  The external validity of RCTs has been 
repeatedly questioned (Cartwright, 2011; Cartwright & Munro, 2010) and the value of a 
systematically performed comparison of treatment modalities, balanced for preference 
represents a far more readily convertible currency of knowledge than a large scale 
demonstration of treatment equivalence might have been.   
 
 The second paper in this companion set is even more unique, and may be of even greater 
interest to many of the readers of this journal.  The LAC study attempted to do something no 
other substantial RCT has taken on to my knowledge.  Using a considerable (almost 50%) 
subsample of participants, the investigators applied what is probably the most robust measure 
of ‘structural change’ currently available (Cierpka, Grande, Rudolf, von der Tann, & Stasch, 
2007) to assess, at least from one perspective, the mechanisms of change that might have 
underpinned the therapeutic work in the two arms of the trial.  In some ways the findings are 
clear and unequivocal.  At one year improvements could not be with any greater confidence 
assigned to structural change in psychoanalytic psychotherapy than in cognitive behaviour 
therapy. The authors reach out to Lane and colleagues (2015) who postulate emotional change 
to be a common factor across modalities.  At three years, by contrast, the authors report 
positive structural change to be uniquely associated with symptomatic improvement in the 
psychoanalytic treatment group alone. Given that both groups improved, the pattern of findings 
suggests that there may be unique therapeutic mechanisms at work for the two treatment arms.  
Obviously this would be a particularly interesting finding if a comparable in depth process 
focused outcome measure was available for those who were randomised or chose to be in the 
CBT arm of the trial. 
 
Nevertheless, I suggest there is something extraordinary and important to celebrate here.  For 
the first time a dose-response relationship has been systematically established and clinically 
illustrated in a treatment trial of any kind of psychological therapy.  As perhaps the most 
sophisticated reviewer of this field, Alan Kazdin has pointed out, psychological therapies 
singularly fail to demonstrate meaningful relationships between theoretically purported change 
mechanisms and observed therapeutic improvements (Kazdin, 2007, 2009; Kazdin & Blase, 
2011).  The authors are therefore to be warmly congratulated for delivering such a unique and 
important finding.   
 
The LAC study is perhaps the best, most carefully mounted comparison study of psychoanalytic 
study available to us to date. Amongst its strong features are well trained therapists fully 
committed to the orientation under scrutiny performing in a naturalistic context with real patients 
but following a well-scripted process orientated treatment manual. There are other studies 
where CBT yielded comparable results to psychodynamic therapy, but often in these instances 
what the treatments had in common was relatively poor performance compared to generally 
expected outcome (e.g. Driessen et al., 2013). In other studies where relatively good outcomes 
were observed, the comparison group was an unmonitored treatment as usual (P. Fonagy, 
Rost, et al., 2015). LAC does well on all important counts.  
 
Do I have a wish list in relation to the next stage of analysing the results of this unique 
investigation? I guess I do. I, along with many others in the field, feel impatient about using 
heterogeneous clinical categories such as depression in organising our scholarship about what 
we know in relation to treatment effectiveness. Currently colleagues and I are actively engaged 
in trying to break down categories such as major depression into constituent hierarchically 
organised components. As we all know, comorbidity is the rule not the exception in mental 
disorders (e.g. Barlow, Sauer-Zavala, Carl, Bullis, & Ellard, 2014; Cummings, Caporino, & Kendall, 
2014; Ormel et al., 2015).  We wish to understand the clinical significance of the co-occurrence 
of diagnoses by statistically isolating aspects of individual presentations that belong to a general 
vulnerability to mental disorder, what Caspi and colleagues (2014) termed the p factor, from the 
spectral level or syndrome level influences. It would be intriguing to see if psychodynamic 
psychotherapy is more likely to impact at the level of general psychopathology while CBT has 
syndromal or spectral impacts. I would also be intrigued to know if our prediction of changes, at 
least at one year, are associated with changes in epistemic trust and consequent social and 
contextual changes which could account for the limited impact of structural change at this phase 
of the therapeutic process (P. Fonagy, Luyten, & Allison, 2015).  
 
But then there are so many questions and time is the enemy of us all. 
 
 
REFERENCES 
 
Barlow, D.H., Sauer-Zavala, S., Carl, J.R., Bullis, J.R., & Ellard, K.K. (2014). The nature, 
diagnosis, and treatment of neuroticism. Clinical Psychological Science, 2(3), 344-365. 
doi: 10.1177/2167702613505532 
Cartwright, N. (2011). A philosopher's view of the long road from RCTs to effectiveness. Lancet, 
377(9775), 1400-1401. doi: 10.1016/S0140-6736(11)60563-1 
Cartwright, N., & Munro, E. (2010). The limitations of randomized controlled trials in predicting 
effectiveness. Journal of Evaluation in Clinical Practice, 16(2), 260-266. doi: 
10.1111/j.1365-2753.2010.01382.x 
Caspi, A., Houts, R. M., Belsky, D. W., Goldman-Mellor, S. J., Harrington, H., Israel, S., . . . 
Moffitt, T. E. (2014). The p factor: One general psychopathology factor in the structure of 
psychiatric disorders? Clinical Psychological Science, 2(2), 119-137. doi: 
10.1177/2167702613497473 
Cierpka, M., Grande, T., Rudolf, G., von der Tann, M., & Stasch, M. (2007). The 
Operationalized Psychodynamic Diagnostics System: Clinical Relevance, Reliability and 
Validity. Psychopathology, 40(4), 209-220.  
Cuijpers, P., Karyotaki, E., Reijnders, M., & Ebert, D. D. (2018). Was Eysenck right after all? A 
reassessment of the effects of psychotherapy for adult depression. Epidemiol Psychiatr 
Sci, 1-10. doi: 10.1017/S2045796018000057 
Cummings, C. M., Caporino, N. E., & Kendall, P. C. (2014). Comorbidity of anxiety and 
depression in children and adolescents: 20 years after. Psychological Bulletin, 140(3), 
816-845. doi: 10.1037/a0034733 
Driessen, E., Van, H. L., Don, F. J., Peen, J., Kool, S., Westra, D., . . . Dekker, J. J. (2013). The 
efficacy of cognitive-behavioral therapy and psychodynamic therapy in the outpatient 
treatment of major depression: A randomized clinical trial. American Journal of 
Psychiatry, 170(9), 1041-1050. doi: 10.1176/appi.ajp.2013.12070899 
Fonagy, P, Cottrell, D, Phillips, J., Bevington, D., Glaser, D., & Allison, E. (2014). What works 
for whom? A critical review of treatments for children and adolescents (2nd ed.). New 
York, NY: Guilford Press. 
Fonagy, P. (2010). Psychotherapy research: Do we know what works for whom? British Journal 
of Psychiatry, 197(2), 83-85. doi: 10.1192/bjp.bp.110.079657 
Fonagy, P. (2015). The effectiveness of psychodynamic psychotherapies: An update. World 
Psychiatry, 14(2), 137-150. doi: 10.1002/wps.20235 
Fonagy, P., Luyten, P., & Allison, E. (2015). Epistemic petrification and the restoration of 
epistemic trust: A new conceptualization of borderline personality disorder and its 
psychosocial treatment. Journal of Personality Disorders, 29(5), 575-609. doi: 
10.1521/pedi.2015.29.5.575 
Fonagy, P., Rost, F., Carlyle, J. A., McPherson, S., Thomas, R., Fearon, R. M. P., . . . Taylor, D. 
(2015). Pragmatic randomized controlled trial of long-term psychoanalytic psychotherapy 
for treatment-resistant depression: The Tavistock Adult Depression Study (TADS). World 
Psychiatry, 14(3), 312-321. doi: 10.1002/wps.20267 
Kazdin, A. E. (2007). Mediators and mechanisms of change in psychotherapy research. Annual 
Review of Clinical Psychology, 3, 1-27. doi: 10.1146/annurev.clinpsy.3.022806.091432 
Kazdin, A. E. (2009). Understanding how and why psychotherapy leads to change. 
Psychotherapy Research, 19(4-5), 418-428. doi: 10.1080/10503300802448899 
Kazdin, A. E., & Blase, S. L. (2011). Rebooting psychotherapy research and practice to reduce 
the burden of mental illness. Perspectives on Psychological Science, 6(1), 21-37. doi: 
Doi 10.1177/1745691610393527 
Leichsenring, F., Luyten, P., Hilsenroth, M. J., Abbass, A., Barber, J. P., Keefe, J. R., . . . 
Steinert, C. (2015). Psychodynamic therapy meets evidence-based medicine: A 
systematic review using updated criteria. Lancet Psychiatry, 2(7), 648-660. doi: 
10.1016/S2215-0366(15)00155-8 
Ormel, J., Raven, D., van Oort, F., Hartman, C. A., Reijneveld, S. A., Veenstra, R., . . . 
Oldehinkel, A. J. (2015). Mental health in Dutch adolescents: A TRAILS report on 
prevalence, severity, age of onset, continuity and co-morbidity of DSM disorders. 
Psychological Medicine, 45(2), 345-360. doi: 10.1017/S0033291714001469 
Pybis, J., Saxon, D., Hill, A., & Barkham, M. (2017). The comparative effectiveness and 
efficiency of cognitive behaviour therapy and generic counselling in the treatment of 
depression: evidence from the 2(nd) UK National Audit of psychological therapies. BMC 
Psychiatry, 17(1), 215. doi: 10.1186/s12888-017-1370-7 
Watzke, B., Ruddel, H., Jurgensen, R., Koch, U., Kriston, L., Grothgar, B., & Schulz, H. (2010). 
Effectiveness of systematic treatment selection for psychodynamic and cognitive-
behavioural therapy: Randomised controlled trial in routine mental healthcare. British 
Journal of Psychiatry, 197(2), 96-105. doi: 10.1192/bjp.bp.109.072835 
Woll, C. F. J., & Schönbrodt, F. D. ( 2018, August 18). . A Series of Meta-Analytic Tests of the 
Efficacy of Long-Term Psychoanalytic Psychotherapy. . from 
https://doi.org/10.31234/osf.io/d2a3s 
 
 
